Cargando…
Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer
Inactivation of Capicua (CIC) or upregulation of yes-associated protein 1, YAP1, leads to broad RAS-RAF-MEK-ERK inhibitor resistance and tumor progression in multiple human cancers. Despite these shared malignant phenotypes, it remains unclear whether CIC and YAP1 are mechanistically linked. Here, w...
Autores principales: | Kim, Ji Won, Luck, Cuyler, Wu, Wei, Ponce, Rovingaile Kriska, Lin, Yone Kawe, Gupta, Nehal, Okimoto, Ross A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9674208/ https://www.ncbi.nlm.nih.gov/pubmed/36198276 http://dx.doi.org/10.1016/j.celrep.2022.111443 |
Ejemplares similares
-
WEE1 kinase is a therapeutic vulnerability in CIC-DUX4 undifferentiated sarcoma
por: Ponce, Rovingaile Kriska M., et al.
Publicado: (2022) -
Inactivation of Capicua drives cancer metastasis
por: Okimoto, Ross A., et al.
Publicado: (2016) -
The CIC-ERF co-deletion underlies fusion-independent activation of ETS family member, ETV1, to drive prostate cancer progression
por: Gupta, Nehal, et al.
Publicado: (2022) -
Regulation and function of capicua in mammals
por: Lee, Yoontae
Publicado: (2020) -
ERK phosphorylation disrupts the intramolecular interaction of capicua to promote cytoplasmic translocation of capicua and tumor growth
por: Park, Jongmin, et al.
Publicado: (2022)